Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Knudsen, Peder
1985.
Chemotherapy With Neuroleptics.
Acta Psychiatrica Scandinavica,
Vol. 72,
Issue. S322,
p.
51.
Gift, Thomas
Plum, Kathleen
and
Price, Margorie
1985.
Depot fluphenazine and plasma prolactin.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 9,
Issue. 4,
p.
407.
Laursen, A. Lund
and
Gerlach, J.
1986.
Antipsychotic effect of remoxipride, a new substituted benzamide with selective antidopaminergic activity.
Acta Psychiatrica Scandinavica,
Vol. 73,
Issue. 1,
p.
17.
Kimber, Nigel M.
Marriott, Peter F.
Norman, Trevor R.
and
Burrows, Graham D.
1986.
Plasma fluphenazine concentrations in outpatients receiving fluphenazine decanoate (Modecate).
Human Psychopharmacology: Clinical and Experimental,
Vol. 1,
Issue. 2,
p.
89.
Sieberns, S.
1988.
Aktuelle Kernfragen in der Psychiatrie.
p.
216.
Sramek, John J.
Potkin, Steven G.
and
Hahn, Rhoda
1988.
Neuroleptic Plasma Concentrations and Clinical Response: In Search of a Therapeutic Window.
Drug Intelligence & Clinical Pharmacy,
Vol. 22,
Issue. 5,
p.
373.
Jørgensen, Aksel
and
Aaes-jørgensen, Tove
1988.
Phannacokinetic Variations of Zuclopenthixol and Flupentixol Administered Orally or Intramuscularly as retard or Depot Formulations.
Nordisk Psykiatrisk Tidsskrift,
Vol. 42,
Issue. 6,
p.
501.
Jolley, A. G.
Hirsch, S. R.
McRink, A.
and
Manchanda, R.
1989.
Trial of brief intermittent neuroleptic prophylaxis for selected schizophrenic outpatients: clinical outcome at one year..
BMJ,
Vol. 298,
Issue. 6679,
p.
985.
Remington, G.
1989.
Pharmacotherapy of Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 34,
Issue. 3,
p.
211.
1989.
Current Perspectives Pharmacotherapy of Schizophrenia.
The Canadian Journal of Psychiatry,
Vol. 34,
Issue. 5,
p.
457.
Dahl, S. G.
1990.
Pharmacokinetics of antipsychotic drugs in man.
Acta Psychiatrica Scandinavica,
Vol. 82,
Issue. S358,
p.
37.
Kapfhammer, H.-P.
1990.
Thioxanthene.
p.
173.
Soni, S. D.
Sampath, G.
Shah, A.
and
Krska, J.
1992.
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Acta Psychiatrica Scandinavica,
Vol. 85,
Issue. 5,
p.
354.
Leonard, Brian E.
1993.
Antipsychotic Drugs and their Side-Effects.
p.
3.
Curry, Stephen H.
1993.
Antipsychotic Drugs and their Side-Effects.
p.
127.
Ereshefsky, L.
1995.
Schizophrenie.
p.
149.
DESTA, Z
KERBUSCH, T
and
FLOCKHART, D
1999.
Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6).
Clinical Pharmacology & Therapeutics,
Vol. 65,
Issue. 1,
p.
10.
Remington, Gary
Kapur, Shitij
and
Zipursky, Bob
2001.
Early Intervention in Psychotic Disorders.
p.
167.
Chapron, Brian D.
Dinh, Jean C.
Toren, Paul C.
Gaedigk, Andrea
and
Leeder, J. Steven
2020.
The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites.
Drug Metabolism and Disposition,
Vol. 48,
Issue. 11,
p.
1113.
eLetters
No eLetters have been published for this article.